Business Description
![Aptevo Therapeutics Inc Aptevo Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000B4XC.png?14)
Aptevo Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US03835L1089
Description
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.97 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.85 | |||||
Debt-to-EBITDA | -0.19 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 33 | |||||
3-Year EPS without NRI Growth Rate | 35.2 | |||||
3-Year FCF Growth Rate | 52 | |||||
3-Year Book Growth Rate | -44.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.58 | |||||
9-Day RSI | 20.07 | |||||
14-Day RSI | 23.83 | |||||
6-1 Month Momentum % | -89.78 | |||||
12-1 Month Momentum % | -98.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.92 | |||||
Quick Ratio | 1.92 | |||||
Cash Ratio | 1.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -64 | |||||
Shareholder Yield % | -95.75 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -186.21 | |||||
ROA % | -101.21 | |||||
ROIC % | -331.4 | |||||
ROC (Joel Greenblatt) % | -467.65 | |||||
ROCE % | -139.95 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.03 | |||||
Price-to-Tangible-Book | 0.03 | |||||
EV-to-EBIT | 0.13 | |||||
EV-to-EBITDA | 0.14 | |||||
EV-to-Forward-Revenue | 0.07 | |||||
EV-to-FCF | 0.16 | |||||
Price-to-Net-Current-Asset-Value | 0.39 | |||||
Earnings Yield (Greenblatt) % | 769.23 | |||||
FCF Yield % | -1796.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:APVO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptevo Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -99.411 | ||
Beta | 1.34 | ||
Volatility % | 93.61 | ||
14-Day RSI | 23.83 | ||
14-Day ATR ($) | 0.084293 | ||
20-Day SMA ($) | 0.604822 | ||
12-1 Month Momentum % | -98.74 | ||
52-Week Range ($) | 0.29 - 80.96 | ||
Shares Outstanding (Mil) | 4.08 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aptevo Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aptevo Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Aptevo Therapeutics Inc Frequently Asked Questions
What is Aptevo Therapeutics Inc(APVO)'s stock price today?
The current price of APVO is $0.31. The 52 week high of APVO is $80.96 and 52 week low is $0.29.
When is next earnings date of Aptevo Therapeutics Inc(APVO)?
The next earnings date of Aptevo Therapeutics Inc(APVO) is 2024-08-09 Est..
Does Aptevo Therapeutics Inc(APVO) pay dividends? If so, how much?
Aptevo Therapeutics Inc(APVO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |